Rapid generation of broad T-cell immunity in humans after a single injection of mature dendritic cells
Dhodapkar MV et al (1999) Rapid generation of broad T-cell immunity in humans after a single injection of mature dendritic cells. J Clin Invest 104:173-180
TRANCE-and CD40 ligand-matured dendritic cells reveal MHC class I-restricted T cells specific for autologous tumor in late-stage ovarian cancer patients
Schlienger K et al (2003) TRANCE-and CD40 ligand-matured dendritic cells reveal MHC class I-restricted T cells specific for autologous tumor in late-stage ovarian cancer patients. Clin Cancer Res 9(4):1517-1527
Placebo-controlled phase III trial of immunologic therapy with sipuleu-cel-T (APC8015) in patients with metastatic, asymptomatic hormone refractory prostate cancer
Small EJ et al (2006) Placebo-controlled phase III trial of immunologic therapy with sipuleu-cel-T (APC8015) in patients with metastatic, asymptomatic hormone refractory prostate cancer. J Clin Oncol 24:3089-3094
Dendritic cells derived from metastatic cancer patients vaccinated with allogeneic dendritic cell-autologous tumor cell hybrids express more CD86 and induce higher levels of interferon-gamma in mixed lymphocyte reactions
Neves AR et al (2005) Dendritic cells derived from metastatic cancer patients vaccinated with allogeneic dendritic cell-autologous tumor cell hybrids express more CD86 and induce higher levels of interferon-gamma in mixed lymphocyte reactions. Cancer Immunol Immunother 54:61-66
Vaccination of dendritic cells loaded with interleukin-12-secreting cancer cells augments in vivo antitumor immunity: Characteristics of syngeneic and allogeneic antigen-presenting cell cancer hybrid cells
Suzuki T et al (2005) Vaccination of dendritic cells loaded with interleukin-12-secreting cancer cells augments in vivo antitumor immunity: characteristics of syngeneic and allogeneic antigen-presenting cell cancer hybrid cells. Clin Cancer Res 11:58-66
Superior anti-tumor protection and therapeutic efficacy of vaccination with allogeneic and semiallogeneic dendritic cell/tumor cell fusion hybrids for murine colon adenocarcinoma
Yasuda T et al (2007) Superior anti-tumor protection and therapeutic efficacy of vaccination with allogeneic and semiallogeneic dendritic cell/tumor cell fusion hybrids for murine colon adenocarcinoma. Cancer Immunol Immunother 56:1025-1036
Innate immune defense in visceral leishmaniasis: Cytokine mediated protective role by allogeneic effector cell
Manna PP et al (2010) Innate immune defense in visceral leishmaniasis: cytokine mediated protective role by allogeneic effector cell. Vaccine 28:803-810
The mechanism of CD47-dependent killing of T cells: Hetero-trimeric Gi -dependent inhibition of protein kinase A
Manna PP, Frazier WA (2003) The mechanism of CD47-dependent killing of T cells: hetero-trimeric Gi -dependent inhibition of protein kinase A. J Immunol 170:3544-3553